The need for pharmaceutical care in the prevention of coronary heart disease: An exploratory study in acute myocardial infarction patients

Pharmacy World and Science

Volumn 26, Issue 2, 2004, Pages 96-101

  Chinwong, Surarong ^d   Reid, Fiona ^b   McGlynn, Steve ^a   Hudson, Steve ^a   Flapan, Andy ^c  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b Hypertension Management   (United Kingdom)

^c NHS LOTHIAN   (United Kingdom)

^d Lothian Univ Hospitals NHS Trust ^*

Author keywords

Clinical guidelines; Coronary heart disease; Pharmaceutical care; Primary prevention; Scotland; Secondary prevention

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; STATIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORONARY RISK; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PATIENT COMPLIANCE; PHARMACEUTICS; PHARMACY; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIMARY PREVENTION; Q WAVE; RISK FACTOR; SECONDARY PREVENTION;

ADULT; AGED; AGED, 80 AND OVER; CHOLESTEROL; CORONARY DISEASE; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PHARMACY SERVICE, HOSPITAL; PRIMARY PREVENTION; RISK FACTORS; SCOTLAND; SMOKING;

EID: 1842479890     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:PHAR.0000018599.47002.e7     Document Type: Article

References (27)

1. Report: Death registration 1999; cause England and Wales. Health Statistic Quarterly Summer 2000. London: The Stationery Office, 2000; 64-70.
2. Scottish Health Statistic 2000. Edinburgh: ISD Publications, 2001.
3. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 1999; 353: 1547-57.
4. National Service Framework for Coronary Heart Disease. Modern Standard & Service Models. London: Department of Health, 2000.
5. Saving lives: Our Healthier Nation; presented to parliament by the Secretary of State for Health by Command of Her Majesty, July 1999. London: The Stationery Office, 1999.
6. Towards a Healthier Scotland - a White Paper on Health: Scottish Office, 1999.
7. Scottish Intercollegiate Guidelines Network. Lipid and the primary prevention of coronary heart disease. Edinburgh: SIGN Secretariat, 1999.
8. Scottish Intercollegiate Guidelines Network. Secondary prevention of coronary heart disease following myocardial infarction. Edinburgh: SIGN Secretariat, 2000.
9. Scottish Intercollegiate Guidelines Network. Management of Stable Angina. A national clinical guideline. Edinburgh: SIGN Executive, 2001.
10. Clinical Standards Board for Scotland. Clinical Standards: Secondary Prevention following Acute Myocardial Infarction. Edinburgh: Clinical Standards Board for Scotland, 2000.
11. van der Weijden T, Grol R. Preventing recurrent coronary heart disease. We need to attend more to implementing evidence based practice. BMJ 1998; 316: 1400-1.
12. Primatesta P, Poulter NR. Lipid concentrations and the use of lipid lowering drugs: evidence from a national cross sectional survey. BMJ 2000; 321: 1322-5.
13. Bowker TJ, Clayton TC, Ingham J, McLennan NR, Hobson HL, Pyke SD, et al. A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events). Heart 1996; 75: 334-42.
14. Campbell NC, Thain J, Deans HG, Ritchie LD, Rawles JM. Secondary prevention in coronary heart disease: baseline survey of provision in general practice. BMJ 1998; 316: 1430-4.
15. Woods KL, Ketley D, Lowy A, Agusti A, Hagn C, Kala R, et al. Beta-blockers and antithrombotic treatment for secondary prevention after acute myocardial infarction. Towards an understanding of factors influencing clinical practice. The European Secondary Prevention Study Group. Eur Heart J 1998; 19: 74-9.
16. Feder G, Griffiths C, Eldridge S, Spence M. Effect of postal prompts to patients and general practitioners on the quality of primary care after a coronary event (POST): randomised controlled trial. BMJ 1999; 318: 1522-6.
17. McCormick D, Gurwitz JH, Lessard D, Yarzebski J, Gore JM, Goldberg RJ. Use of aspirin, beta-blockers, and lipid-lowering medications before recurrent acute myocardial infarction: missed opportunities for prevention? Arch Intern Med 1999; 159: 561-7.
18. Bradley F, Morgan S, Smith H, Mant D. Preventive care for patients following myocardial infarction. The Wessex Research Network (WReN). Fam Pract 1997; 14: 220-6.
19. Brady AJ, Oliver MA, Pittard JB. Secondary prevention in 24 431 patients with coronary heart disease: survey in primary care. BMJ 2001; 322: 1463.
20. Wallis EJ, Ramsay LE, UI Haq I, Ghahramani P, Jackson PR, Rowland-Yeo K et al. Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population [published erratum appears in BMJ 2000, 320(7241): 1034]. BMJ 2000; 320: 671-6.
21. Wallis EJ, Ramsay LE, UI Haq I, Ghahramani P, Jackson PR, Rowland-Yeo K et al. Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population [published erratum appears in BMJ 2000, 320(7241): 1034]. BMJ 2000; 320: 671-6.
22. Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association. Heart 1998; 80: S1-29.
23. Ramsay L, Williams B, Johnston G, MacGregor G, Poston L, Potter J, et al. Guidelines for management of hypertension: report of the third working party of the British Hypertension Society. J Hum Hypertens 1999; 13: 569-92.
24. Jones AF, Walker J, Jewkes C, Game FL, Bartlett WA, Marshall T, et al. Comparative accuracy of cardiovascular risk prediction methods in primary care patients. Heart 2001; 85: 37-43.
25. Scottish Intercollegiate Guidelines Network. Hypertension in Older People. Edinburgh: SIGN Secretariat, 2001.
26. Prophylaxis for patients who have experienced a myocardial infarction. London: National Institute for Clinical Excellence, 2001.
27. Coronary Heart Disease/Stroke Task Force Report. Edinburgh: NHS Scotland. Scottish Executive, 2001.